Your browser doesn't support javascript.
loading
Antihypertensive drug prescription patterns, rationality, and adherence to Joint National Committee-7 hypertension treatment guidelines among Indian postmenopausal women.
Tandon, Vishal R; Sharma, Sudhaa; Mahajan, Shagun; Mahajan, Annil; Khajuria, Vijay; Mahajan, Vivek; Prakash, Chander.
Affiliation
  • Tandon VR; Department of Pharmacology and Therapeutics, Govt. Medical College, Jammu, Jammu and Kashmir, India.
  • Sharma S; Department of Obstetrics and Gyanecology, Govt. Medical College, Jammu, Jammu and Kashmir, India.
  • Mahajan S; Department of Nephrology-Superspecialty Hospital, Govt. Medical College, Jammu, Jammu and Kashmir, India.
  • Mahajan A; Department of Internal Medicine, Govt. Medical College, Jammu, Jammu and Kashmir, India.
  • Khajuria V; Department of Pharmacology and Therapeutics, Govt. Medical College, Jammu, Jammu and Kashmir, India.
  • Mahajan V; Department of Pharmacology and Therapeutics, Govt. Medical College, Jammu, Jammu and Kashmir, India.
  • Prakash C; Department of Pharmacology and Therapeutics, Govt. Medical College, Jammu, Jammu and Kashmir, India.
J Midlife Health ; 5(2): 78-83, 2014 Apr.
Article in En | MEDLINE | ID: mdl-24970986
AIM OF STUDY: The aim of this study is to evaluate antihypertensive drug prescription patterns, rationality and adherence to Joint National Committee (JNC-7) hypertension (HT) treatment recommendations among Indian postmenopausal women (PMW). MATERIALS AND METHODS: An observational and cross-sectional prospective prescription audit study was carried over a period of 1 year. A total of 500 prescriptions prescribed to PMW for diagnosed HT, were identified for one point analysis. Drug prescription patterns/trends, and their adherence to JNC-7 report as well as rationality using WHO guide to good prescribing was assessed. RESULTS: In the monotherapy, category angiotensin receptor blockers (ARBs) accounted (24.8%), calcium channel blockers (CCBs) (19.4%), angiotensin converting enzyme inhibitors (ACEIs) (11%), beta blockers (BBs) (2.8%), and diuretics (2%) of the total prescription. Individually, amlodipine was maximally prescribed in 16.4%. 31.6% had double combination, whereas 2.2% and 1% had triple and four drug combinations, respectively. About 3.6% of the prescription contained antihypertensive combination along with other class of drug. ARBs + diuretic were observed in 11%, CCBs + BB 10% and ACEI + diuretic in 2.6% of the total prescriptions. Among the combination therapy amlodipine + atenolol (8.4%), telmisartan + hydrochlorothiazide (6%) and losartan + hydrochlorothiazide (4.4%) were maximally prescribed. 84.21% (P < 0.001) of the prescription showed nonadherence as per recommendations for pre-HT. 100% and 43.25% adherence rates were noticed for Stage 1 HT (P < 0.001) and Stage 2 HT (P > 0.05) patients. CONCLUSION: Antihypertensive prescription trends largely adhere to existing guidelines and are rational except polypharmacy, generic and fixed dose combinations prescribing, were some of the common pharmacologically considered irrationality noticed.
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline Language: En Journal: J Midlife Health Year: 2014 Document type: Article Affiliation country: India Country of publication: India

Full text: 1 Collection: 01-internacional Database: MEDLINE Type of study: Guideline Language: En Journal: J Midlife Health Year: 2014 Document type: Article Affiliation country: India Country of publication: India